Holen Sie sich die Stockscreener-App
1.416
2.61%
0.036
Schlusskurs vom Vortag:
$1.38
Offen:
$1.4006
24-Stunden-Volumen:
6,732
Relative Volume:
0.00
Marktkapitalisierung:
$2.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.59M
KGV:
-0.00103
EPS:
-1373
Netto-Cashflow:
$-9.25M
1W Leistung:
-0.28%
1M Leistung:
-38.70%
6M Leistung:
-21.77%
1J Leistung:
-60.88%
1-Tages-Spanne:
$1.40
$1.42
1-Wochen-Bereich:
$1.235
$1.45
52-Wochen-Spanne:
$1.235
$10.20
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Firmenname
Bluejay Diagnostics Inc
Sektor
Branche
Telefon
(978) 631-0152
Adresse
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Vergleichen Sie BJDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.42 | 2.50M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
128.80 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.53 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.52 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.70 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.87 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bluejay Diagnostics Inc Aktie (BJDX) Neueste Nachrichten
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bluejay Diagnostics Inc Stock Analysis and ForecastFlag and Pennant Patterns & Exceptional Capital Investment - earlytimes.in
Why Bluejay Diagnostics Inc. stock could outperform in 20252025 Volatility Report & Low Drawdown Trading Techniques - newser.com
How Bluejay Diagnostics Inc. stock reacts to oil pricesQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Why Bluejay Diagnostics Inc. stock could benefit from AI revolution2025 Price Targets & Low Risk Entry Point Tips - newser.com
How geopolitical tensions affect Bluejay Diagnostics Inc. stockJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Statistical indicators supporting Bluejay Diagnostics Inc.’s strengthEarnings Beat & High Conviction Buy Zone Picks - newser.com
Using data filters to optimize entry into Bluejay Diagnostics Inc.Earnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Tick level data insight on Bluejay Diagnostics Inc. volatilityJuly 2025 Weekly Recap & Weekly Momentum Picks - newser.com
Custom watchlist performance reports with Bluejay Diagnostics Inc.Analyst Downgrade & Weekly High Momentum Picks - newser.com
Risk adjusted return profile for Bluejay Diagnostics Inc. analyzed2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
What Wall Street predicts for Bluejay Diagnostics Inc. stock priceInsider Buying & Fast Gain Stock Trading Tips - newser.com
Analyzing drawdowns of Bluejay Diagnostics Inc. with statistical toolsPortfolio Update Summary & AI Based Buy and Sell Signals - newser.com
Bluejay Diagnostics, Inc. (BJDX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Why Bluejay Diagnostics Inc. stock remains on watchlists2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
Is Bluejay Diagnostics Inc. stock a safe buy before earningsJobs Report & Daily Entry Point Alerts - newser.com
Bluejay Diagnostics Corporate Update, Advancing Clinical Milestones and Strategic Partnerships - MarketScreener
Bluejay Diagnostics reports progress on sepsis test clinical trial By Investing.com - Investing.com Nigeria
Will Bluejay Diagnostics Inc. stock maintain momentum in 2025Earnings Trend Report & High Conviction Investment Ideas - newser.com
Bluejay Diagnostics Reports Q3 Results and Updates - TipRanks
Bluejay Diagnostics, Inc. Provides Q3 2025 Financial and Corporate Update - TradingView
[8-K] Bluejay Diagnostics, Inc. Reports Material Event | BJDX SEC FilingForm 8-K - Stock Titan
Bluejay Diagnostics reports progress on sepsis test clinical trial - Investing.com
Finanzdaten der Bluejay Diagnostics Inc-Aktie (BJDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):